Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 1 (1 total).

Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler KM, Shastri SS. 2016. Secondary prevention of cervical cancer: American Society of Clinical Oncology resource-staffed clinical practice guidelines. Journal of Global Oncology [published online before print October 28, 2016],

Annotation: This guideline offers guidance on secondary prevention of cervical cancer. Contents include key recommendations for screening; triage; and treatment of women with precursor lesions. Recommendations for special populations, such as women who are HIV positive, immunosuppressed, pregnant, postpartum, or women who have had hysterectomies are also addressed. Topics include developing infrastructure for HPV testing, diagnosis, and treatment in settings without current mass screening; cost and policy implications, guideline implementation, and future directions.

Contact: American Society of Clinical Oncology, 2318 Mill Road, Suite 800, Alexandria, VA 22314, Telephone: (571) 483-1300 Fax: (703) 299-1044 E-mail: [email protected] Web Site: http://www.asco.org Available from the website.

Keywords: Advocacy, Cervical cancer, DNA testing, Diagnosis, Disease prevention, Human papillomavirus, International health, Medical treatment, Oral cancer, Oral health, Postpartum women, Pregnant women, Primary care, Triage, Women', s health

   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.